cytarabine and interleukin-8

cytarabine has been researched along with interleukin-8 in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (25.00)18.2507
2000's2 (50.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aulitzky, WE; Bemb, W; Huber, C; Kolbe, K; Peschel, C; Schönbohn, H; Schuler, M1
Bruserud, Ø; Ersvaer, E; Gjertsen, BT; Skavland, J; Ulvestad, E1
de Bont, ES; Kamps, WA; Koetse, HA; Rings, EH; Stellaard, F; Tissing, WJ; van Vliet, MJ1
Ast, AM; Blenc, AM; Cogle, CR; Drusbosky, LM; Ge, Y; Geddes, T; Lipten, SD; Madlambayan, GJ; Maywood, M; Miller, R; Ostrov, DA; Pezeshkian, MB; Pompeu, Y; Salgado, AD; Vijay, V; Vue, GS1

Trials

1 trial(s) available for cytarabine and interleukin-8

ArticleYear
Citrulline as a marker for chemotherapy induced mucosal barrier injury in pediatric patients.
    Pediatric blood & cancer, 2009, Dec-15, Volume: 53, Issue:7

    Topics: Acute Disease; Adolescent; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Carbohydrates; Cell Death; Child; Child, Preschool; Citrulline; Cytarabine; Daunorubicin; DNA; Enterocytes; Etoposide; Feces; Female; Humans; Infant; Interleukin-8; Intestinal Absorption; Leukemia, Myeloid; Leukocyte L1 Antigen Complex; Male; Mitoxantrone; Models, Biological; Mucositis; Stomatitis

2009

Other Studies

3 other study(ies) available for cytarabine and interleukin-8

ArticleYear
Plasma levels of IL-1, TNF alpha, IL-6, IL-8, G-CSF, and IL1-RA during febrile neutropenia: results of a prospective study in patients undergoing chemotherapy for acute myelogenous leukemia.
    Annals of hematology, 1995, Volume: 71, Issue:4

    Topics: Adolescent; Adult; Animals; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Cytokines; Dacarbazine; Female; Fever; Granulocyte Colony-Stimulating Factor; Humans; Interleukin 1 Receptor Antagonist Protein; Interleukin-1; Interleukin-2; Interleukin-6; Interleukin-8; Leukemia, Myeloid, Acute; Male; Middle Aged; Mitoxantrone; Neutropenia; Nimustine; Prospective Studies; Sialoglycoproteins; Tumor Necrosis Factor-alpha; Vincristine

1995
Effects of interferon gamma on native human acute myelogenous leukaemia cells.
    Cancer immunology, immunotherapy : CII, 2007, Volume: 56, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Apoptosis; Cell Proliferation; Chemokine CXCL9; Chemokines, CXC; Cytarabine; Endothelium, Vascular; Female; Fibroblasts; Flow Cytometry; fms-Like Tyrosine Kinase 3; Granulocyte Colony-Stimulating Factor; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Interferon gamma Receptor; Interferon-gamma; Interleukin-1beta; Interleukin-3; Interleukin-8; Leukemia, Lymphoid; Leukemia, Myeloid; Lymphocyte Activation; Male; Middle Aged; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Osteoblasts; Phosphorylation; Receptors, Interferon; Signal Transduction; STAT1 Transcription Factor; Stromal Cells; T-Lymphocytes; Tumor Cells, Cultured

2007
Interleukin-8 blockade prevents activated endothelial cell mediated proliferation and chemoresistance of acute myeloid leukemia.
    Leukemia research, 2019, Volume: 84

    Topics: Antineoplastic Agents; Biomarkers; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cytarabine; Drug Resistance, Neoplasm; Endothelial Cells; Humans; Interleukin-8; Leukemia, Myeloid, Acute; Models, Molecular; Structure-Activity Relationship

2019